OncoMatch/Clinical Trials/NCT06756074
Reinforced Pancreaticojejunostomy With or Without glubran2
Is NCT06756074 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2) for pancreatic fistula.
Treatment: Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2) — Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Pancreatic Cancer
Demographics
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT06756074 currently recruiting?
Yes, this trial is currently recruiting patients.
Is there an age limit?
Yes. Patients must be 75 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages